VETERAN STRATEGIST AND LEADER TO GUIDE THE CONTINUED EXPANSION AND GROWTH
OF PRECISION’S INDUSTRY-LEADING GLOBAL CLINICAL TRIALS SOLUTIONS
January 27, 2020– New York, NY – Precision for Medicine, the first comprehensive, fully-integrated biomarker-driven clinical research services organization, today announced that veteran healthcare leader Mairead Kehoe has been named its new Executive Vice President, responsible for overseeing its global clinical solutions delivery.
In adding Ms. Kehoe’s expertise and leadership, Precision builds upon its novel, biomarker-driven approach— integrating translational sciences and clinical trials— and strengthens its industry-leading position as experts in early development and late-phase trials for innovative life changing therapies. Precision’s growing global footprint now includes 34 offices worldwide with nearly 2000 employees, and is managing trals in over 35 countries.
Ms. Kehoe joins Precision with 25+ years of industry experience from biotech, CRO and biopharma clinical research industry, spanning all aspects of global clinical development. Her experience includes management and leadership positions focused on the strategic planning and quality conduct of global clinical programs encompassing end-to-end drug development operations, from early development through to product approval – seeing first-hand the positive impact of quality and thoughtful clinical development.
Most recently, Ms. Kehoe held the position of Corporate Vice President of Global Clinical Quality Assurance (GCP) & Data Sharing/Disclosure at Celgene Corp. where she was responsible for the global leadership of the GCP programs for Early Development, R&D and Medical Affairs. Prior to this, Mairead held the position of Vice President, Global Clinical Operations and was responsible for the strategic planning, oversight and leadership for the global Clinical Operations functions at Celgene. Prior to joining Celgene, Ms. Kehoe was the Executive Director, Global Clinical Operations for i3/Ingenix and was responsible for the strategic and operational leadership across core therapeutic areas.
Guiding the delivery of Precision’s global clinical solutions, Ms. Kehoe will continue to evolve Precision’s integrated team approach, utilizing clinical science, exceptional data integrity and quality operations to facilitate timely and targeted endpoint-driven decision making– providing clients with a unique, end-to-end operating platform.
Discussing Ms. Kehoe’s unique experience and qualifications, Pat Devitt, President, Precision for Medicine, Clinical Solutions adds, “We are extremely fortunate to be adding a veteran leader such as Mairead to drive the growth and expansion of our global clinical solutions offering— expertly guiding us in our growth strategy as well as in the proactive planning and quality execution of programs and cross-organizational processes.”
Expressing her enthusiasm for the opportunity, Ms. Kehoe explains, “I am very excited to be part of the Precision for Medicine Team. It is rewarding to work alongside such a group of highly experienced and passionate professionals focused on quality drug development, with the common goal of bringing forward meaningful treatment options for patients and their families dealing with challenging diseases.”
About Precision for Medicine,
Precision for Medicine, part of Precision Medicine Group, is the first comprehensive, fully integrated CRO devoted to oncology and rare disease innovation. With over 1900 experts in 34 offices worldwide, Precision offers novel clinical trial designs, industry-leading operational and medical experts, and advanced biomarker solutions for pharma and biotech innovators. For more information, please visit: https://www.precisionmedicinegrp.com/pfmord/.
—
Media Contact:
Louis Landon
Precision Medicine Group Media Relations
310-984-7707
louis.landon@precisionformedicine.com
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
Senior Vice President, Clinical Operations
Respected leader managing the execution and delivery of all oncology clinical trials to ensure the highest quality service.
Chief Medical Officer, Clinical Solutions
Oncologist, hematologist and veteran expert in clinical research, clinical practice and development of pharmaceuticals, biologic products and immune modulation therapies. Primary consultant to the Moonshot 2020 program and an authority in optimizing clinical trial designs to accelerate product approval. Significant experience and credibility with the FDA as well as regulatory authorities in Europe, Japan and other countries.
Global Head of Strategic Development, Clinical Solutions
Notable authority in global operations, dedicated to fostering team spirit of excellence and collaboration with internal and external partners. Veteran of the quest to improve oncology therapies and extend lives, including 15+ years in oncology drug development, building on 10 years in obstetrics and women’s health.
Senior Vice President, Project Management and Clinical Operations Rare and Orphan Solutions
Global business strategist with more than 20 years of project and clinical management experience in the biopharma and CRO industries, spanning the full scope of studies. In-depth expertise in many therapeutic areas, including pediatric oncology, pediatric chronic pain, cancer pain, oncology, cardiovascular, CNS, biomarkers, infectious disease, gastroenterology, ophthalmology, Cystic Fibrosis, pediatric auto-inflammatory disorders, genetic sampling and medical device. Passionate about exploring ways to lessen the patient burden.
Senior Vice President, European Solutions
Industry leader in managing large global clinical trials. Co-founder of Argint International, a CRO providing clinical research and regulatory services to the pharmaceutical industry throughout central and south eastern Europe. Holds a masters in biology from Johannes Gutenberg-University in Mainz, Germany.
Senior Director, Europe Lead Biological
Leading expert in flow cytometry and systems biology and senior bioinformatics scientist. Core focus on exploratory immunological biomarker data analyses. Long-standing experience in the pharmaceutical industry. Holds a doctorate in cell biology from Friedrich Miescher Institute in Basel, Switzerland.
Senior Vice President, Business Operations Rare and Orphan Solutions
Accomplished and versatile leader with clinical development and R&D experience gained from academia, biopharma, and several top CROs. Unique skills developed as a laboratory researcher at the UCSD School of Medicine, in quality control in the biotech industry, in clinical operations, and as a senior executive. Dedicated to helping innovative companies bring new therapies to patients and families in greatest need.
Senior Director, Translational Biology & Biomarker Development
Authority in utilizing human primary biological tissue and cells in research and drug discovery. Developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer. Expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells, Dendritic cells (pDCc/mDCs), and MDSCs. Strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. Scientific leader for Precision’s Biomaterials commercial sourcing.
President
Recognized industry leader focused on combining cutting-edge technology, strategic program design, and operational excellence to help life sciences companies effectively address the increasing evidence demands and need to accelerate research initiatives. Previous experience spans the execution of phase I-IV clinical trials, specialty lab services, biospecimen logistics and banking, risk management, and patient support initiatives.
Medical Director, Biospecimen Solutions
Visionary dedicated to enabling collaborations that help facilitate efficient translational research, discovery and development. Full-time pathologist and founder of the uniquely consultative biospecimens company Glas. Believes that forward-thinking pathologists and laboratorians should play a critical role in realizing the promise of translational medicine.
Senior Vice President
Visionary leader with more than 25 years of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.
Senior Vice President, Diagnostics Solutions
Strategic visionary and healthcare industry veteran operating at the intersection of reimbursement, health economics, clinical science, and marketing strategy. Expertise encompasses all aspects of market access, reimbursement, and evidence development strategy, with a particular focus on personalized medicine, advanced molecular and companion diagnostics, and targeted therapies. Has launched successful products, guided major investment and acquisition decisions, and driven favorable coverage and payment determinations by public and private payers alike. Speaker and author.
Senior Vice President, Research Services
Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
Senior Vice President, Biometrics Rare and Orphan Solutions
Seasoned veteran of the pharmaceutical and biotech industries both through CROs and sponsor companies. Provides statistical, technical, and strategic expertise for preclinical studies, INDs, Phase I-IV clinical studies, eCTDs, and postmarketing studies. Statistical expertise includes study design, protocol review, and writing and reviewing analysis plans and statistical reports. Skilled at representing clients at meetings with regulatory authorities, and as a statistical consultant for programs at all phases of development.
Senior Advisor, Rare Disease Solutions
Industry leader and founder of Agility Clinical, passionate about helping underserved patient populations. Keenly focused on orphan drug development with extensive experience in biostatistics, data management, and clinical operations. Accomplished executive leader with numerous awards, including, “Most Admired CEO”, “100 Most Inspiring People in the Pharmaceutical Industry”, “Athena Pinnacle Award for Women in Science and Technology”, and Ernst & Young “Entrepreneur of the Year” Finalist. Prior positions include founder and CEO of Synteract, a full-service, international contract research organization serving biopharma companies.
Senior Vice President, Operations & Customer Solutions
Extensive industry expertise across the pharmaceutical and biotech space-translational research, data management, and statistical support-with a focus in precision medicine-guided efforts in drug and diagnostic development. Subject matter expert in genomics. Pioneered approaches in biomarker data management and has led Biometrics operations on over 70 clinical studies.
Senior Vice President, Business Development
Clinical research veteran with a focus on strategic initiatives in the laboratory and biospecimen arena. Dedicated to helping pharmaceutical and life sciences clients innovate, develop, and commercialize next generation medical products.
Scientific Liaison
Respected scientist and research investigator with expertise spanning biotechnology, medical science, technology development, and data analysis. Partners cross-functionally to identify and advance projects related to validation studies, method development, and reference standards.
Vice President, Biospecimen Solutions
Pioneer in the field of biospecimen procurement and co-founder of ProMedDx. Leader in the delivery of services for organizations in the biotechnology industry, including clinical study support and biostorage. Experienced executive with a demonstrated career of building innovative patient-centric biotech clinical programs. Focused on addressing the growing need for highly annotated, regulatory-compliant human biospecimens by the life science research communities.
Vice President, Biospecimen Solutions
Long-standing leader in the life sciences and in-vitro diagnostics industries. Co-founder of ProMedDx, a full suite of biospecimen solutions connecting biopharma teams to 1000s of clearly stratified and annotated cohorts. Expertise spanning operations, finance, human resources, government grant applications, and corporate strategy.
Senior Vice President, Laboratory Operations
Experienced senior leader spanning the academic, pharmaceutical, and CRO industries. Specific expertise in biotherapeutics and vaccines for preclinical and clinical development programs and in identifying the appropriate immunochemistry assays for new development programs. Broad record of accomplishment leading global teams, delivering business strategies, developing business, and ensuring operational excellence.
Chief Operating Officer, Oncology Solutions
Expert strategist for the pharmaceutical, CRO, and healthcare industries. Offers extensive multi-disciplinary drug development experience at the project, compound, and portfolio levels. Takes a sophisticated approach to the operations, infrastructure, and growth of Precision’s oncology division.
Senior Vice President, In Vitro Diagnostics and Quality
Leader and innovator in the GMP/ISO/FDA/EU-regulated in vitro diagnostic (IVD) industry. Spearheads regulatory approvals worldwide for both novel and traditional IVD assays and products, as well as laboratory developed tests in the United States. Builds ground-up quality systems, meeting the requirements of US FDA, ISO 13485, CLIA, and CAP.
Senior Director, Europe Lead Informatics
Respected expert in mathematics and fundamental and theoretical computer science. Strong focus on genetics. Developer of innovative bioinformatics algorithms for SNP analyses and genome-wide association studies. Avid proponent of and proactive contributor to the open source community.
Senior Director, Europe Lead Operations
Distinguished expert in the analysis of large-scale, high-throughput genomics and genetics data. Statistical programmer combining computational and experimental methods in various therapeutic areas, including oncology and autoimmune disease.
Senior Director, Business Development
Influential strategy expert in end-to-end bioinformatics and artificial intelligence solutions for biomarker-guided drug development, maximizing the value and utility of biomarker data in clinical trials, CDx, and diagnostics. Previously CEO of SimplicityBio. Holds a doctorate in molecular and cellular biology from the University of Lausanne.
President, Clinical Solutions
Widely respected industry leader and founder of ACT Oncology. Guides strategic protocol design and study optimization on behalf of sponsors. Has extensive experience in Phase I-IV trials for most indications, including solid tumor and hematologic malignancies. Leads integrated teams to combine the strength of biomarker insights with clinical outcome data to optimize the development pathway.
Senior Director, Business Development, Oncology Solutions
30+ year healthcare industry veteran bridging business development efforts and program implementation for optimal client satisfaction. Serves as the primary business development contact for biotech and pharmaceutical clients on the west coast.
Senior Director, Client Solutions
Industry leader with deep expertise in healthcare technology focused on using artificial intelligence to help biopharma and diagnostic companies solve the question, “Which therapy, when, and for which patient?” Extensive industry knowledge across the pharmaceutical and biotech space—translational informatics, biomarker R&D. Holds an MBA and is passionate about exploring interfaces between people and technology for effective communication.
General Manager, Biospecimen Solutions
Respected vetran of the biospecimen and biomarker laboratory services industry. Honed his expertise through leadership roles in organizations including Roche, Cancer Genetics, and BioServe. Holds a Master of Public Health and a Masters of Business Administration from the Johns Hopkins University.
Senior Vice President, Business Operations
Vetran with deep knowledge of the contract research/pharmaceutical services industry. Provides project leadership and executive support to clients. Directs operational functions, resourcing, and business strategy internally, structuring oncology operations to match client needs.
Executive Director, Business Operations
Long-standing international CRO authority in the oncology drug development industry. Expertise spanning commercial operations, oncology and clinical operations, partnership development, and investigator networking.
Senior Director, Business Development
Research professional in both academia and industry, focused on bringing immune monitoring services to autoimmunity and tumor-immunology clinical trials. Specialist in innate and adaptive immunity, immunoassay development, onco-immunology, autoimmunity, target validation and preclinical biomarker discovery, and workflow and SOP design.
Managing Director, Translational Informatics and Diagnostic Sciences
Industry expert, leading regulatory submissions, translational informatics, and biomarker R&D for pharmaceutical and biotechnology companies. Focus on precision medicine-guided efforts, strategy, and medical device/diagnostic development. Global responsibility for translational informatics R&D efforts. Has led the development of novel methodologies for patient stratification and biomarker guided clinical trial design.
Director, Neurology Solutions
Trusted leader driving multi-site research programs that leverage proprietary state-of-the-art technologies to identify, validate, and integrate next-generation biomarkers to advance clinical trials for a wide range of neurological indications. Able to generate novel hypotheses, then identify and develop the right methods to answer the right scientific questions.
Senior Vice President, European Solutions
Industry leader with expertise managing large multinational clinical trials in 20+ countries across Europe, North America and APAC. Dedicated to providing quality, flexible and cost-effective solutions for clinical development programs.Co-founder of Argint International, a full-service CRO for phase I-IV clinical research trials. Holds a degree in microbiology from University of Warwick, United Kingdom.
Senior Vice President, Research
Inventor, industry expert, founder and leader of Epiontis. Developed the patents forming the basis of Epiontis’s intellectual property. Conducted pre- and postdoctoral research at the Center for Molecular Biology and Biomedicine (ZMBH) of the University of Heidelberg, Germany, and the R.W. Johnson Pharmaceutical Research Institute, San Diego, California, USA. Received a BSc from the Imperial College of Science, Technology, and Medicine, London, and a PhD in Biochemistry from the University of London.
Vice President, Oncology Solutions Site Network
Industry vetran and leader of Precision Oncology Site Network. Clear focus on consistently optimizing start-up at both academic and community-based sites across the United States and Europe. Oversaw the world’s largest phase 1 program for cancer research and treatment at the renowned University of Texas MD Anderson Cancer Center.
Senior Vice President, Product Development & Systems Integration
Distinguished expert working across the pharmaceutical and biotech space, leading regulatory submissions, translational informatics, and biomarker R&D. Clear focus on precision medicine-guided efforts, strategy, and medical device/diagnostic development. Led numerous analytical R&D efforts and developed novel methodologies to harmonize and analyze data from high-throughput assays, translating it to value at the patient level.
Vice President Immune Monitoring Solutions
Veteran biochemist, industry expert, cofounder of Epiontis. Holds a Master’s in Biochemistry from Humboldt University, a PhD from the Charité University Clinic receiving the Charité Research Award, and an MBA from the Berlin School of Economics and Law, Berlin, Germany.
